Advanced Search
Search Results
6557 total results found
Table 21.10.1.3 Comparison of intensive versus con
Table 21.10.1.3 Comparison of intensive versus conventional therapy in the prevention of moderately increased albuminuria in type 1(DCCT + EDIC) and newly diagnosed type 2 (UKPDS) patients
Table 21.10.1.4 Cross- tabulation of latest classi
Table 21.10.1.4 Cross- tabulation of latest classification of chronic kidney disease and historical definition of diabetic kidney disease
Table 21.10.2.1 The classification of primary syst
Table 21.10.2.1 The classification of primary systemic vasculitis, updated in the 2012 Chapel Hill Consensus statement
Table 21.10.2.2 Classification of rapidly progress
Table 21.10.2.2 Classification of rapidly progressiveglomerulonephritis according to renal immunofluorescence andcirculating immune reactants 21.10.2 The kidney in systemic vasculitis 4991 are present in granulomata and at sites of vasculitic injury. They hav...
Takayasu’s arteritis
Takayasu’s arteritis
Tertiary prevention
Tertiary prevention
Title
Title 1 Oxford Textbook of Medicine SIXTH EDITION Volume 4: Sections 22–30 EDITED BY John D. Firth Christopher P. Conlon Timothy M. Cox
Treatment
Treatment section 21 Disorders of the kidney and urinary tract 4994 The haemorrhagic risks of renal biopsy are increased by ur- aemia, anticoagulation, and clotting factor deficiency after plasma exchange. Renal biopsy should not be considered essential when ...
UAER
UAER section 21 Disorders of the kidney and urinary tract 4982 increased albuminuria. Accurate data on GFR are not given in many of these studies, but in type 1 patients, long-term ACE inhibitor therapy appears to stabilize renal function after an initial re...
Urinary tract obstruction 5124 Muhammad M. Yaqoob
Urinary tract obstruction 5124 Muhammad M. Yaqoob and Kieran McCafferty
Why does intensive glycaemic control fail to compl
Why does intensive glycaemic control fail to completelyprevent development of moderately increasedalbuminuria?
cover
cover 2 ONLY FOR SALE IN INDIA, BANGLADESH, SRI LANKA, NEPAL, BHUTAN, AND MYANMAR AND NOT FOR EXPORT THEREFROM. NOT FOR SALE IN ANY OTHER COUNTRY IN THE WORLD SIXTH EDITION VOLUME 4 edited by John D. Firth Christopher P. Conlon Timothy M. Cox Oxford Textbook o...
22.1 Introduction to haematology 5169 Chris Hatton
22.1 Introduction to haematology 5169 Chris Hatton ESSENTIALS Haematology is the study of the composition, function, and diseases of the blood. The approach to a patient suspected of having a haematological disorder begins with taking a history (particularly n...
22.2 Haematopoiesis 5172 22.2.1 Cellular and molec
22.2 Haematopoiesis 5172 22.2.1 Cellular and molecular basis of haematopoiesis 5172 Paresh Vyas and N. Asger Jakobsen CONTENTS 22.2.1 Cellular and molecular basis of haematopoiesis 5172 Paresh Vyas and N. Asger Jakobsen 22.2.2 Diagnostic techniques in the a...
22.2.2 Diagnostic techniques in the assessment of
22.2.2 Diagnostic techniques in the assessment of haematological malignancies 5181 Wendy N. Erber 22.2.2 Diagnostic techniques in the assessment of haematological malignancies 5181 and retention of maturing haematopoietic cells within the marrow as shown by t...
22.3 Myeloid disease 5189 22.3.1 Granulocytes in h
22.3 Myeloid disease 5189 22.3.1 Granulocytes in health and disease 5189 Joseph Sinning and Nancy Berliner CONTENTS 22.3.1 Granulocytes in health and disease 5189 Joseph Sinning and Nancy Berliner 22.3.2 Myelodysplastic syndromes 5197 Charlotte K. Brierley...
22.3.2 Myelodysplastic syndromes 5197 Charlotte K.
22.3.2 Myelodysplastic syndromes 5197 Charlotte K. Brierley and David P. Steensma 22.3.2 Myelodysplastic syndromes 5197 for neutrophils and eosinophils, leukotrienes, prostaglandins, and platelet-activating factor. They arise in the marrow from the same myel...
22.3.3 Acute myeloid leukaemia 5205 Nigel Russell
22.3.3 Acute myeloid leukaemia 5205 Nigel Russell and Alan Burnett 22.3.3 Acute myeloid leukaemia 5205 Greenberg PL, et al. (2012). Revised international prognostic scoring system for myelodysplastic syndromes. Blood, 120, 2454–65. Haferlach T, et al. (2014)...